awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35097319-655A5C34-988D-4337-9F8B-2F028D5479A8
Q35097319-655A5C34-988D-4337-9F8B-2F028D5479A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35097319-655A5C34-988D-4337-9F8B-2F028D5479A8
The use of novel agents in the treatment of relapsed and refractory multiple myeloma
P2860
Q35097319-655A5C34-988D-4337-9F8B-2F028D5479A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35097319-655A5C34-988D-4337-9F8B-2F028D5479A8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dfc38d6b1aed929f101c2633ce0df7a5b9b4ea47
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.